Champlain Investment Partners, LLC Atri Cure, Inc. Transaction History

Champlain Investment Partners, LLC

$16.9 Billion
Q1 2024

A detailed history of Champlain Investment Partners, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 2,681,000 shares of ATRC stock, worth $61 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

2,681,000

Previous 2,105,395 27.34%

Holding current value

$61 Million

Previous $75.1 Million 8.54%

% of portfolio

0.48%

Previous 0.45%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$28.21 - $37.78 $16.2 Million - $21.7 Million	575,605 Added 27.34%	2,681,000 $81.6 Million
Q4 2023 Feb 13, 2024	BUY	$32.99 - $43.25 $8.37 Million - $11 Million	253,855 Added 13.71%	2,105,395 $75.1 Million
Q3 2023 Nov 13, 2023	BUY	$41.12 - $57.73 $1.69 Million - $2.38 Million	41,155 Added 2.27%	1,851,540 $81.1 Million
Q2 2023 Aug 11, 2023	SELL	$40.44 - $49.6 $3.3 Million - $4.05 Million	-81,710 Reduced 4.32%	1,810,385 $89.4 Million
Q1 2023 May 12, 2023	SELL	$35.87 - $47.22 $1.71 Million - $2.25 Million	-47,645 Reduced 2.46%	1,892,095 $78.4 Million

Q4 2022 Feb 13, 2023	SELL	$33.48 - $47.45 $2.38 Million - $3.37 Million	-71,000 Reduced 3.53%	1,939,740 $86.1 Million
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $15 Million - $20.6 Million	391,760 Added 24.2%	2,010,740 $78.6 Million
Q2 2022 Aug 12, 2022	BUY	$35.1 - $66.01 $12 Million - $22.7 Million	343,160 Added 26.9%	1,618,980 $66.2 Million
Q1 2022 May 12, 2022	BUY	$57.43 - $71.39 $3.29 Million - $4.09 Million	57,270 Added 4.7%	1,275,820 $83.8 Million
Q4 2021 Feb 10, 2022	SELL	$63.4 - $87.14 $124,898 - $171,665	-1,970 Reduced 0.16%	1,218,550 $84.7 Million
Q3 2021 Nov 12, 2021	SELL	$69.28 - $84.46 $23.6 Million - $28.8 Million	-340,715 Reduced 21.82%	1,220,520 $84.9 Million
Q2 2021 Aug 12, 2021	SELL	$64.13 - $80.18 $39.4 Million - $49.2 Million	-613,905 Reduced 28.22%	1,561,235 $124 Million
Q1 2021 May 13, 2021	BUY	$53.79 - $66.98 $2.13 Million - $2.65 Million	39,560 Added 1.85%	2,175,140 $143 Million
Q4 2020 Feb 12, 2021	BUY	$34.56 - $57.55 $2.29 Million - $3.81 Million	66,160 Added 3.2%	2,135,580 $119 Million
Q3 2020 Nov 13, 2020	BUY	$38.36 - $46.91 $15.7 Million - $19.2 Million	410,185 Added 24.72%	2,069,420 $82.6 Million
Q2 2020 Aug 13, 2020	SELL	$31.78 - $51.19 $1.08 Million - $1.74 Million	-33,990 Reduced 2.01%	1,659,235 $74.6 Million
Q1 2020 May 14, 2020	BUY	$24.49 - $43.84 $10.9 Million - $19.4 Million	443,585 Added 35.5%	1,693,225 $56.9 Million
Q4 2019 Feb 13, 2020	BUY	$24.06 - $32.51 $13.8 Million - $18.7 Million	574,205 Added 85.01%	1,249,640 $40.6 Million
Q3 2019 Nov 14, 2019	BUY	$23.81 - $32.52 $16.1 Million - $22 Million	675,435 New	675,435 $16.8 Million

Others Institutions Holding ATRC

# of Institutions

237

Shares Held

46.7M

Call Options Held

95.7K

Put Options Held

119K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.06B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Champlain Investment Partners, LLC with notifications on news.

Account

Champlain Investment Partners, LLC Atri Cure, Inc. Transaction History